Evotec SE (EVOTF) Total Non-Current Liabilities (2020 - 2026)

Evotec SE's (EVOTF) quarterly Total Non-Current Liabilities came in at $605063.6 in Q1 2026, down 14.89% year-on-year from $710906.6 in Q1 2025, and down 2.32% quarter-over-quarter from $619465.5 in Q4 2025.

Evotec SE (EVOTF) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Evotec SE has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $605063.6 for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $605063.6, down 14.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $605063.6 (down 14.89% YoY), and the FY2025 annual result was $619465.5, down 99.91% from the prior year.
  • Total Non-Current Liabilities came in at $605063.6 for Q1 2026 at Evotec SE, down from $619465.5 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $747.2 million in Q4 2022 to a low of $404.41 in Q2 2022.
  • The 5-year median for Total Non-Current Liabilities is $699141.1 (2025), against an average of $177.4 million.
  • Across the five-year window, Total Non-Current Liabilities climbed 22.55% in 2022 and plunged 99.91% in 2025, its largest moves.
  • Evotec SE's Total Non-Current Liabilities stood at $747.2 million in 2022, then dropped by 3.81% to $718.7 million in 2023, then retreated by 8.5% to $657.6 million in 2024, then slumped by 99.91% to $619465.5 in 2025, then declined by 2.32% to $605063.6 in 2026.
  • The last three Total Non-Current Liabilities figures came in at $605063.6 (Q1 2026), $619465.5 (Q4 2025), and $699208.3 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Evotec SE - - - 605,063.60

Historic Data

Download Data
DateValue
Mar 31, 2026 605,063.60
Dec 31, 2025 619,465.55
Sep 30, 2025 699,208.34
Jun 30, 2025 655,728.40
Mar 31, 2025 710,906.63
Dec 31, 2024 657.61 Mn
Sep 30, 2024 756,366.83
Dec 31, 2023 718.71 Mn
Dec 31, 2022 747.19 Mn
Sep 30, 2022 699,073.90
Jun 30, 2022 404.41
Mar 31, 2022 601,058.99
Dec 31, 2021 609.69 Mn
Sep 30, 2021 614,870.98
Dec 31, 2020 631.22 Mn